Xencor, Inc. (XNCR)
23.72
-0.16
(-0.67%)
USD |
NASDAQ |
Sep 25, 14:55
Xencor Cash from Operations (TTM) : -205.81M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -205.81M |
| March 31, 2026 | -186.52M |
| December 31, 2025 | -135.12M |
| September 30, 2025 | -133.24M |
| June 30, 2025 | -128.44M |
| March 31, 2025 | -157.41M |
| December 31, 2024 | -196.45M |
| September 30, 2024 | 34.59M |
| June 30, 2024 | 33.33M |
| March 31, 2024 | 60.47M |
| December 31, 2023 | 85.11M |
| September 30, 2023 | -120.53M |
| June 30, 2023 | -94.41M |
| March 31, 2023 | -11.94M |
| December 31, 2022 | 24.48M |
| September 30, 2022 | 110.71M |
| June 30, 2022 | 72.85M |
| March 31, 2022 | 18.93M |
| December 31, 2021 | -16.85M |
| September 30, 2021 | -61.56M |
| June 30, 2021 | -26.40M |
| March 31, 2021 | -44.43M |
| December 31, 2020 | -5.004M |
| September 30, 2020 | -41.66M |
| Date | Value |
|---|---|
| June 30, 2020 | -44.28M |
| March 31, 2020 | 92.56M |
| December 31, 2019 | 64.37M |
| September 30, 2019 | 67.17M |
| June 30, 2019 | 63.34M |
| March 31, 2019 | -74.24M |
| December 31, 2018 | -79.76M |
| September 30, 2018 | -69.64M |
| June 30, 2018 | -62.84M |
| March 31, 2018 | -47.30M |
| December 31, 2017 | -33.60M |
| September 30, 2017 | -42.72M |
| June 30, 2017 | 94.86M |
| March 31, 2017 | 98.37M |
| December 31, 2016 | 94.62M |
| September 30, 2016 | 106.56M |
| June 30, 2016 | 12.01M |
| March 31, 2016 | 14.46M |
| December 31, 2015 | 26.67M |
| September 30, 2015 | 24.65M |
| June 30, 2015 | -19.59M |
| March 31, 2015 | -18.45M |
| December 31, 2014 | -21.35M |
| September 30, 2014 | -19.64M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| UroGen Pharma Ltd. | -170.43M |
| MeiraGTx Holdings Plc | 13.69M |
| Regeneron Pharmaceuticals, Inc. | 4.681B |
| Ironwood Pharmaceuticals, Inc. | 185.56M |
| MacroGenics, Inc. | -63.72M |